P. Beart

发表

The Concise Guide to Pharmacology 2013/14: Overview

Adam J Pawson, Stephen P. H. Alexander, A. A. Khan, 2013, British journal of pharmacology.

Type I and II metabotropic glutamate receptors mediate depressor and bradycardic actions in the nucleus of the solitary tract of anaesthetized rats.

N. Jones, R. Widdop, J. Monn, 1999, European journal of pharmacology.

The Rho kinase inhibitor Fasudil up‐regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes

L. Bischof, Cl Lau, P. Beart, 2011, British journal of pharmacology.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview

Arthur Christopoulos, Christopher Southan, Stephen PH Alexander, 2017, British journal of pharmacology.

Structure-activity relationships of competitive NMDA receptor antagonists.

N. Cheung, R. Dutton, D. O'Callaghan, 1996, European journal of pharmacology.

N-0434, A very potent and specific new D-2 dopamine receptor agonist.

J. Kebabian, P. Beart, A. Horn, 1984, European journal of pharmacology.

Bidirectional transport of NMDA receptor and ionophore in the vagus nerve.

D. Lodge, R. Summers, M. Cincotta, 1989, European journal of pharmacology.

Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement

R. D. O'Shea, P. Beart, R. D. O’Shea, 2007, British journal of pharmacology.

Hydroxamic acids. V. The alkylation of O-alkylarylhydroxamic acids

P. Beart, A. Ward, 1974 .

The selectivity of some ergot derivatives for alpha 1 and alpha 2-adrenoceptors of rat cerebral cortex.

P. Beart, G. Mcpherson, 1983, European journal of pharmacology.

Type I and II metabotropic glutamate receptors regulate the outflow of [3H]D-aspartate and [14C]gamma-aminobutyric acid in rat solitary nucleus.

N. Jones, J. Monn, P. Beart, 1998, European journal of pharmacology.

Hippocampal lesions induced by microinjection of the nitric oxide donor nitroprusside.

P. Beart, R. Loiacono, 1992, European journal of pharmacology.

Effects of the CCK(A) receptor antagonists SR 27897B and PD140548 on baroreflex function in conscious rats.

R. Widdop, P. Beart, M. W. Bunting, 1997, European journal of pharmacology.

Yoga and GABA: New Insights from the Science

P. Beart, T. Hinton, Johnston Gar., 2020 .

Diverse roles for nitric oxide in synaptic signalling after activation of NMDA release-regulating receptors

P. Beart, N. Jones, P. Beart, 1994, Neuropharmacology.

Neuropharmacology of addiction—setting the scene

P. Kalivas, A. Lawrence, P. Beart, 2008, British journal of pharmacology.

3,4‐DIHYDROXYPHENYLACETIC ACID (DOPAC) AND THE RAT MESOLIMBIC DOPAMINERGIC PATHWAY: DRUG EFFECTS AND EVIDENCE FOR SOMATODENDRITIC MECHANISMS

P. Beart, A. Gundlach, P. Beart, 1980, British journal of pharmacology.

Effect of GABAergic drugs on dopamine catabolism in the nigrostriatal and mesolimbic dopaminergic pathways of the rat

A. Gundlach, P. Beart, 1981, The Journal of pharmacy and pharmacology.

The N-methyl-D-aspartate (NMDA) receptor antagonist MK-801, attenuates the Bezold-Jarisch reflex in the anaesthetized rat

M. Costa, W. Louis, S. Lewis, 1987, Neuropharmacology.

Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat

N. Young, S. Lewis, P. Beart, 1989, Experimental Neurology.

Receptor autoradiography with [3H]L-glutamate reveals the presence and axonal transport of glutamate receptors in vagal afferent neurones of the rat.

D. Lodge, B. Jarrott, S. Lewis, 1987, European Journal of Pharmacology.

[3H]Spiperone Labels Non‐Cyclase‐Linked Dopamine Receptors in the Ventral Tegmental Area of Rat Brain

A. Gundlach, P. Beart, D. McDonald, 1982, Journal of neurochemistry.